Schedule 13D ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Security class unavailable · CUSIP: 76152G100
Event date: 2020-12-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 26.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-138040
- Form type
- SC 13D
- Filer
- Bhat Laxminarayan
- CIK
- CIK 1818245
- Filed
- Dec 21, 2020
- Reporting period
- Dec 14, 2020
- Description
- Schedule 13D beneficial ownership